IMMUNOGEN, INC.

Patent Owner

Compare Create Portfolio
3Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 88150
 
 
 
C07K PEPTIDES 4869
 
 
 
C07D HETEROCYCLIC COMPOUNDS 39107
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1358
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1084
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1085
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9147
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5176
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 283
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2120

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0165,067 COMPOUNDS TO FIBROBLAST GROWTH FACTOR RECEPTOR-3 (FGFR3) AND METHODS OF TREATMENTDec 11, 14Jun 18, 15[A61K]
2015/0166,482 METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERSNov 12, 14Jun 18, 15[C07D]
2015/0132,323 Anti-FOLR1 Immunoconjugate Dosing RegimensOct 08, 14May 14, 15[A61K, C07K]
2015/0110,816 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESJun 04, 14Apr 23, 15[A61K, C07K]
2015/0099,874 CYTOTOXIC BENZODIAZEPINE DERIVATIVESOct 10, 14Apr 09, 15[C07D]
2015/0093,388 Antibodies and Assays for Detection of Folate Receptor 1Aug 29, 14Apr 02, 15[G01N, A61K, C07K]
2015/0093,397 Methods for Increasing Efficacy of CD37-Based TherapyMar 29, 13Apr 02, 15[G01N, C07K]
2015/0071,949 CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)Aug 14, 14Mar 12, 15[A61K]
2015/0030,616 NOVEL BENZODIAZEPINE DERIVATIVESJun 26, 14Jan 29, 15[C07D, A61K]
2014/0363,451 Anti-FOLR1 Immunoconjugate Dosing RegimensMay 13, 14Dec 11, 14[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,061,995 Cross-linkers and their usesNov 14, 13Jun 23, 15[C07D, A61K, C07K]
9,011,864 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugatesDec 23, 08Apr 21, 15[A61K, B82Y, C07K]
9,012,629 Methods for the acylation of maytansinolSep 26, 13Apr 21, 15[C07D]
8,987,424 CA6 antigen-specific cytotoxic conjugate and methods of using the sameApr 13, 08Mar 24, 15[A61K, C07K]
8,933,205 Process for preparing purified drug conjugatesFeb 25, 13Jan 13, 15[A61K, C07K]
8,921,566 Methods for the preparation of charged crosslinkersOct 03, 13Dec 30, 14[C07D]
8,889,669 Cytotoxic benzodiazepine derivativesMar 14, 13Nov 18, 14[C07D, A61K]
8,840,898 Immunoconjugates targeting syndecan-1 expressing cells and use thereofApr 16, 07Sep 23, 14[A61K]
8,841,425 Cytotoxic agents comprising new maytansinoidsMar 09, 11Sep 23, 14[C07D, A61K, C07K]
8,809,320 Benzodiazepine derivativesFeb 22, 13Aug 19, 14[C07D, A61P, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0295,050 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTSABANSep 14, 12Nov 07, 13[A61K]
2013/0108,620 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANNov 28, 11May 02, 13[A61K]
2012/0282,282 Methods for Decreasing Ocular Toxicity of Antibody Drug ConjugatesABANApr 04, 12Nov 08, 12[A61P, A61K]
2012/0269,827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube CancerABANMar 29, 12Oct 25, 12[A61P, A61K]
2012/0226,025 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATESABANMay 11, 12Sep 06, 12[C07K]
2012/0226,026 POTENT CONJUGATES AND HYDROPHILIC LINKERSABANMay 17, 12Sep 06, 12[C07D, C07K]
8,093,358 Methods of treatment using anti-erbb antibody-maytansinoid conjugatesWithdrawnDec 03, 07Jan 10, 12[C07K]
2011/0300,162 DRUG CONJUGATE COMPOSITIONABANAug 18, 11Dec 08, 11[A61B, A61P, A61K]
2011/0280,890 PRODRUGS OF CC-1065 ANALOGSABANJul 15, 11Nov 17, 11[C07D, A61P, A61K, C07K]
2011/0177,064 Compositions and Methods for Treatment of Ovarian CancerABANJan 21, 11Jul 21, 11[A61P, A61K]
2011/0097,345 NOVEL DOSING REGIMEN AND METHOD OF TREATMENTABANOct 21, 10Apr 28, 11[A61P, A61K]
7,906,545 Prodrugs of CC-1065 analogsExpiredJul 17, 09Mar 15, 11[C07D, A61K]
2011/0008,373 PRODRUGS OF CC-1065 ANALOGSABANSep 20, 10Jan 13, 11[C07F, C07D, A61P, A61K, C07K]
2010/0260,678 ANTI-IGF-I RECEPTOR ANTIBODIESABANApr 30, 10Oct 14, 10[A61P, A61K]
2010/0136,033 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATESABANOct 30, 09Jun 03, 10[A61P, A61K, C07K]
2010/0092,495 POTENT CELL-BINDING AGENT DRUG CONJUGATESABANOct 06, 09Apr 15, 10[A61P, A61K, C07K]
7,655,660 Prodrugs of CC-1065 analogsExpiredJan 05, 07Feb 02, 10[C07D, A61K]
7,655,661 Prodrugs of CC-1065 analogsExpiredJun 23, 08Feb 02, 10[C07D, A61K]
2009/0291,090 ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAMEABANJan 23, 09Nov 26, 09[C12N, C12P, G01N, A61K, C07K]
2009/0162,284 ANTI-IGF-I RECEPTOR ANTIBODYABANOct 15, 08Jun 25, 09[C12N, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.